Forte Biosciences, Inc. to Present at the Chardan Annual Microbiome Medicines Summit on March 8th

Author's Avatar
Feb 24, 2021
Article's Main Image

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, announced today that Paul Wagner, Ph.D., CEO of Forte Biosciences will be presenting at the Chardan Annual Microbiome Medicines Summit on March 8th, 2021.